Prosecution Insights
Last updated: April 19, 2026

Biopharma Law Group, Pllc

5 pending office actions • 4 clients

Portfolio Summary

5
Total Pending OAs
3
Final Rejections
2
Non-Final OAs

Client Portfolio (4 clients)

Client (Assignee)Pending OAs
Murray And Poole Enterprises Ltd. 2
Efferent Labs, Inc. 1
VERIMMUNE INC. 1
Murray And Poole Enterprises, Ltd. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18734231 IMPLANTABLE DEVICES AND METHODS OF USE Efferent Labs, Inc. MESSERSMITH, ERIC J 3791 Non-Final OA Jun 05, 2024
18621631 CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES VERIMMUNE INC. LI, BAO Q 1671 Final Rejection Mar 29, 2024
18367416 SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME Murray And Poole Enterprises Ltd. BARSKY, JARED 1628 Final Rejection Sep 12, 2023
17385734 COLCHICINE SALICYLATE DERIVATIVES AND METHODS OF TREATMENT Murray And Poole Enterprises, Ltd. BARSKY, JARED 1628 Non-Final OA Jul 26, 2021
17308153 METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS Murray And Poole Enterprises Ltd. COPPINS, JANET L 1628 Final Rejection May 05, 2021

Managing Biopharma Law Group, Pllc's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month